Camurus AB (publ) (STO:CAMX)
503.00
-3.00 (-0.59%)
At close: Feb 27, 2026
Camurus AB Employees
Camurus AB had 285 employees as of December 31, 2025. The number of employees increased by 29 or 11.33% compared to the previous year.
Employees
285
Change
29
Growth
11.33%
Revenue / Employee
7.95M SEK
Profits / Employee
2.58M SEK
Market Cap
30.03B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 285 | 29 | 11.33% | 285 | 0 |
| Sep 30, 2025 | 280 | 55 | 24.44% | 280 | 0 |
| Jun 30, 2025 | 267 | 54 | 25.35% | 267 | 0 |
| Mar 31, 2025 | 265 | 47 | 21.56% | 265 | 0 |
| Dec 31, 2024 | 256 | 43 | 20.19% | 238 | 18 |
| Sep 30, 2024 | 225 | 21 | 10.29% | 225 | 0 |
| Jun 30, 2024 | 213 | 14 | 7.04% | 213 | 0 |
| Mar 31, 2024 | 218 | 30 | 15.96% | 218 | 0 |
| Dec 31, 2023 | 213 | 37 | 21.02% | 213 | 0 |
| Sep 30, 2023 | 204 | 34 | 20.00% | 204 | 0 |
| Jun 30, 2023 | 199 | 42 | 26.75% | 199 | 0 |
| Mar 31, 2023 | 188 | 39 | 26.17% | 188 | 0 |
| Dec 31, 2022 | 176 | 28 | 18.92% | 176 | 0 |
| Sep 30, 2022 | 170 | 24 | 16.44% | 170 | 0 |
| Jun 30, 2022 | 157 | 17 | 12.14% | 157 | 0 |
| Mar 31, 2022 | 149 | 12 | 8.76% | 149 | 0 |
| Dec 31, 2021 | 148 | 14 | 10.45% | 148 | 0 |
| Sep 30, 2021 | 146 | 12 | 8.96% | 146 | 0 |
| Jun 30, 2021 | 140 | 8 | 6.06% | 140 | 0 |
| Mar 31, 2021 | 137 | 10 | 7.87% | 137 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Hansa Biopharma AB | 125 |
| BioInvent International AB | 124 |
| BioArctic AB | 122 |
| Diamyd Medical AB | 41 |
| Egetis Therapeutics AB | 40 |
| Vicore Pharma Holding AB | 36 |
| Genovis AB (publ.) | 36 |
| Saniona AB | 31 |
Camurus AB News
- 16 days ago - Camurus AB (publ) (CAMRF) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Camurus reports positive topline results for CAM2056, semaglutide monthly depot - PRNewsWire
- 4 months ago - Camurus AB (publ) (CAMRF) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 9 months ago - Camurus' POSITANO study shows treatment effects with CAM2029 in polycystic liver disease patients - PRNewsWire
- 9 months ago - Camurus and Lilly enter collaboration and license agreement for long-acting FluidCrystal® incretins - PRNewsWire
- 11 months ago - CHMP recommends approval of Oczyesa® for treatment of acromegaly in the EU - PRNewsWire
- 1 year ago - US FDA declines to approve Camurus' rare hormone disorder drug - Reuters
- 1 year ago - New publication shows effectiveness data for weekly and monthly buprenorphine injections in treating opioid dependence in individuals using fentanyl - PRNewsWire